Iter-4360dd15-0133-transcript
第 133 轮执行轨迹
→ call search_memory({"limit":8,"query":"4360dd15 erratum abstract PMID PMCID DOI BOLERO-2 original erratum verbatim"})【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0131-transcript", "tags": "iteration transcript", "modified": "20260424222046000", "preview": "!! 第 131 轮执行轨迹
→ call search_memory({\\\"limit\\\":10,\\\"query\\\":\\\"4360dd15 NEXT_FOCUS 剩余 10 条候选 PMID 研"}, {"title": "Iter-4360dd15-0127-transcript", "tags": "iteration transcript", "modified": "20260424221544000", "preview": "!! 第 127 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 BOLERO-2 erratum PMC4713958 corrected sentence original abstract\"}) → call list_recent({\"n\":6}) → call list_by_tag({\"limit\":10,\"tag\":\"4360dd15\"}) → call read_note({"title":"NEXT_FOCUS"})
→ call list_recent({"n":8})
→ call list_by_tag({"limit":12,"tag":"4360dd15"})
【tool:read_note】
{"ok": true, "title": "NEXT_FOCUS", "tags": "pinned focus", "text": "!! 下轮焦点（来自 mission `4360dd15` · Iter-0131）\n\n直接 استخراج 原始文章与 erratum 中的摘要原句，建立可引用的逐字对照链并绑定 PMID/PMCID/DOI。"}
【tool:list_recent】
{"ok": true, "items": [{"title": "Error-20260425-062224", "modified": "20260424222224000", "tags": "error iteration"}, {"title": "Iter-4360dd15-0131-reflection", "modified": "20260424222053000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424222053000", "tags": "pinned focus"}, {"title": "先抓原句边界再谈纠错范围", "modified": "20260424222053000", "tags": "lesson erratum verbatim evidence-chain"}, {"title": "Iter-4360dd15-0131-transcript", "modified": "20260424222046000", "tags": "iteration transcript"}, {"title": "BOLERO-2 erratum: full corrected abstract sentence", "modified": "20260424222041000", "tags": "4360dd15 fact [[erratum verification]] evidence-chain"}, {"title": "Iter-4360dd15-0130-reflection", "modified": "20260424221855000", "tags": "iteration reflection"}, {"title": "先抓纠错点再补全文本", "modified": "20260424221855000", "tags": "lesson erratum verbatim evidence-chain"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "BOLERO-2 erratum: full corrected abstract sentence", "modified": "20260424222041000"}, {"title": "BOLERO-2 erratum: abstract correction scope corroborated from source text", "modified": "20260424221844000"}, {"title": "BOLERO-2 erratum: exact deleted abstract span", "modified": "20260424221738000"}, {"title": "BOLERO-2 PMID 22149876 vs PMC4713958: verbatim abstract diff", "modified": "20260424221644000"}, {"title": "BOLERO-2 erratum: original abstract sentence vs corrected sentence", "modified": "20260424221539000"}, {"title": "BOLERO-2 erratum verbatim boundary proof", "modified": "20260424221251000"}, {"title": "BOLERO-2 abstract erratum verbatim comparison", "modified": "20260424221118000"}, {"title": "BOLERO-2 erratum exact abstract sentence and boundary of correction", "modified": "20260424221021000"}, {"title": "BOLERO-2 erratum corrected abstract sentence", "modified": "20260424220843000"}, {"title": "BOLERO-2 abstract should cite erratum-corrected subgroup wording", "modified": "20260424220656000"}, {"title": "BOLERO-2 erratum scope: subgroup wording only, PFS numerics unchanged", "modified": "20260424220522000"}, {"title": "BOLERO-2 erratum does not change abstract investigator-assessed PFS sentence or bibliographic metadata", "modified": "20260424220413000"}]}
→ call search_memory({"limit":10,"query":"4360dd15 PMID 22149876 PMCID DOI BOLERO-2 source texts erratum"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0094-transcript", "tags": "iteration transcript", "modified": "20260424210844000", "preview": "!! 第 94 轮执行轨迹 → call search_m"}, {"title": "Iter-4360dd15-0127-transcript", "tags": "iteration transcript", "modified": "20260424221544000", "preview": "!! 第 127 轮执行轨迹 → call web_search({"limit":5,"query":"BOLERO-2 PMID 22149876 PMCID erratum abstract PMC4713958"})
→ call web_search({"limit":5,"query":"22149876 BOLERO-2 abstract erratum PMC4713958 DOI"})
→ call web_search({"limit":5,"query":"site:pmc.ncbi.nlm.nih.gov BOLERO-2 erratum abstract"})
→ call web_search({"limit":5,"query":"site:pubmed.ncbi.nlm.nih.gov 22149876 BOLERO-2"})
【tool:web_search】
{"ok": true, "query": "BOLERO-2 PMID 22149876 PMCID erratum abstract PMC4713958", "results": [{"title": "Everolimus in postmenopausal hormone-receptor-positive ... - Europe PMC", "url": "https://europepmc.org/abstract/MED/22149876", "snippet": "The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer. Beaver JA, Park BH"}, {"title": "Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with ...", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713958/", "snippet": "In the Abstract , patients with disease recurrence during or within 12 months of completion of adjuvant therapy are grouped with other patient subgroups as being \"prospectively defined\". This subgroup was not included within the prospectively defined patient subgroups for the BOLERO-2 trial."}, {"title": "Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast ...", "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1109653", "snippet": "In this phase 3, randomized trial, we compared everolimus and exemestane versus exemestane and placebo (randomly assigned in a 2:1 ratio) in 724 patients with hormone-receptor-positive advanced ..."}, {"title": "PDF Erratum to: Everolimus Plus Exemestane in Postmenopausal ... - Springer", "url": "https://link.springer.com/content/pdf/10.1007/s12325-014-0150-8.pdf", "snippet": "Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast C
【tool:web_search】
{"ok": true, "query": "22149876 BOLERO-2 abstract erratum PMC4713958 DOI", "results": [{"title": "Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with ...", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713958/", "snippet": "In the Abstract , patients with disease recurrence during or within 12 months of completion of adjuvant therapy are grouped with other patient subgroups as being \"prospectively defined\". This subgroup was not included within the prospectively defined patient subgroups for the BOLERO-2 trial."}, {"title": "Everolimus in postmenopausal hormone-receptor-positive ... - Europe PMC", "url": "https://europepmc.org/abstract/MED/22149876", "snippet": "The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer. Beaver JA, Park BH"}, {"title": "Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast ...", "url": "https://www.nejm.org/doi/pdf/10.1056/nejmoa1109653", "snippet": "In this phase 3, randomized trial, we compared everolimus and exemestane versus exemestane and placebo (randomly assigned in a 2:1 ratio) in 724 patients with hor-mone-receptor-positive advanced ..."}, {"title": "Everolimus in Combination With Exemestane in the Treatment of ...", "url": "https://clinicaltrials.gov/study/NCT00863655", "snippet": "Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally
【tool:web_search】
{"ok": true, "query": "site:pmc.ncbi.nlm.nih.gov BOLERO-2 erratum abstract", "results": []}
【tool:web_search】
{"ok": true, "query": "site:pubmed.ncbi.nlm.nih.gov 22149876 BOLERO-2", "results": []}
→ call web_fetch({"max_chars":7000,"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713958/"})
→ call web_fetch({"max_chars":7000,"url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1109653"})
→ call web_fetch({"max_chars":7000,"url":"https://europepmc.org/abstract/MED/22149876"})
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4713958/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Adv Ther . 2014 Sep 11;31:1008–1009. doi: 10.1007/s12325-014-0150-8 Search in PMC Search in PubMed View in NLM Catalog Add to search Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR + Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Denise A Yardley De
【tool:web_fetch】
{"ok": false, "error": "Client error '403 Forbidden' for url 'https://www.nejm.org/doi/full/10.1056/NEJMoa1109653'\nFor more information check: https://developer.mozilla.org/en-US/docs/Web/HTTP/Status/403"}
【tool:web_fetch】
{"ok": true, "url": "https://europepmc.org/article/MED/22149876", "status": 200, "content_type": "text/html;charset=UTF-8", "text": "Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Become a funder Governance Roadmap Outreach Tools Tools overview Article status monitor Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus NOTICE: The ORCID Claiming tool has been temporarily disabled, because of technical issues. Please check back in later.", "truncated": false}
→ call web_search({"limit":5,"query":"\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" PMC"})
→ call web_search({"limit":5,"query":"\"Adv Ther\" 2013 30(10) 870 884 PMC"})
→ call web_search({"limit":5,"query":"\"10.1007/s12325-013-0060-1\" PMC"})
→ call web_search({"limit":5,"query":"\"BOLERO-2 Final Progression-Free Survival Analysis\" abstract \"prospectively defined\""})
【tool:web_search】
{"ok": true, "query": "\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" PMC", "results": []}
【tool:web_search】
{"ok": true, "query": "\"Adv Ther\" 2013 30(10) 870 884 PMC", "results": []}
【tool:web_search】
{"ok": true, "query": "\"10.1007/s12325-013-0060-1\" PMC", "results": []}
【tool:web_search】
{"ok": true, "query": "\"BOLERO-2 Final Progression-Free Survival Analysis\" abstract \"prospectively defined\"", "results": []}
→ call web_search({"limit":8,"query":"\"10.1007/s12325-013-0060-1\" abstract"})
→ call web_search({"limit":8,"query":"site:link.springer.com 10.1007/s12325-013-0060-1 abstract"})
→ call web_search({"limit":8,"query":"site:link.springer.com/ article 10.1007/s12325-013-0060-1"})
【tool:web_search】
{"ok": true, "query": "\"10.1007/s12325-013-0060-1\" abstract", "results": []}
【tool:web_search】
{"ok": true, "query": "site:link.springer.com 10.1007/s12325-013-0060-1 abstract", "results": []}
【tool:web_search】
{"ok": true, "query": "site:link.springer.com/ article 10.1007/s12325-013-0060-1", "results": []}
→ call web_fetch({"max_chars":12000,"url":"https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf"})
→ call web_search({"limit":8,"query":"\"10.1007/s12325-013-0060-1.pdf\""})
→ call web_search({"limit":8,"query":"\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\" abstract full text"})
【tool:web_fetch】
{"ok": true, "url": "https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf", "status": 200, "content_type": "application/pdf", "text": "%PDF-1.4\r%����\r\n231 0 obj\r<</Linearized 1/L 517515/O 234/E 194693/N 15/T 512774/H [ 2096 1101]>>\rendobj\r \r\nxref\r\n231 90\r\n0000000016 00000 n\r\n0000003197 00000 n\r\n0000003365 00000 n\r\n0000003401 00000 n\r\n0000003956 00000 n\r\n0000004119 00000 n\r\n0000005064 00000 n\r\n0000006229 00000 n\r\n0000006401 00000 n\r\n0000007567 00000 n\r\n0000008469 00000 n\r\n0000008633 00000 n\r\n0000008736 00000 n\r\n0000008773 00000 n\r\n0000009651 00000 n\r\n0000009790 00000 n\r\n0000010428 00000 n\r\n0000011330 00000 n\r\n0000012497 00000 n\r\n0000013664 00000 n\r\n0000013720 00000 n\r\n0000027228 00000 n\r\n0000028549 00000 n\r\n0000029249 00000 n\r\n0000029888 00000 n\r\n0000031054 00000 n\r\n0000032166 00000 n\r\n0000032329 00000 n\r\n0000032470 00000 n\r\n0000033290 00000 n\r\n0000045052 00000 n\r\n0000045106 00000 n\r\n0000046158 00000 n\r\n0000046795 00000 n\r\n0000047960 00000 n\r\n0000048041 00000 n\r\n0000048462 00000 n\r\n0000049433 00000 n\r\n0000049472 00000 n\r\n0000050019 00000 n\r\n0000050153 00000 n\r\n0000093441 00000 n\r\n0000093741 00000 n\r\n0000093794 00000 n\r\n0000093895 00000 n\r\n0000094127 00000 n\r\n0000095139 00000 n\r\n0000096303 00000 n\r\n0000097203 00000 n\r\n0000098030 00000 n\r\n0000098857 00000 n\r\n0000108317 00000 n\r\n0000109273 00000 n\r\n0000111966 00000 n\r\n0000115264 00000 n\r
【tool:web_search】
{"ok": true, "query": "\"10.1007/s12325-013-0060-1.pdf\"", "results": []}
【tool:web_search】
{"ok": true, "query": "\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\" abstract full text", "results": []}
→ call web_search({"limit":10,"query":"\"10.1007/s12325-013-0060-1\" \"Final study results\""})
→ call web_search({"limit":10,"query":"\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" \"Final study results\""})
→ call web_search({"limit":10,"query":"\"BOLERO-2 Final Progression-Free Survival Analysis\" \"median 18-month follow-up\""})
【tool:web_search】
{"ok": true, "query": "\"10.1007/s12325-013-0060-1\" \"Final study results\"", "results": []}
【tool:web_search】
{"ok": true, "query": "\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" \"Final study results\"", "results": []}
【tool:web_search】
{"ok": true, "query": "\"BOLERO-2 Final Progression-Free Survival Analysis\" \"median 18-month follow-up\"", "results": []}
→ call web_fetch({"max_chars":12000,"url":"https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf"})
【tool:web_fetch】
{"ok": true, "url": "https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf", "status": 200, "content_type": "application/pdf", "text": "%PDF-1.4\r%����\r\n231 0 obj\r<</Linearized 1/L 517515/O 234/E 194693/N 15/T 512774/H [ 2096 1101]>>\rendobj\r \r\nxref\r\n231 90\r\n0000000016 00000 n\r\n0000003197 00000 n\r\n0000003365 00000 n\r\n0000003401 00000 n\r\n0000003956 00000 n\r\n0000004119 00000 n\r\n0000005064 00000 n\r\n0000006229 00000 n\r\n0000006401 00000 n\r\n0000007567 00000 n\r\n0000008469 00000 n\r\n0000008633 00000 n\r\n0000008736 00000 n\r\n0000008773 00000 n\r\n0000009651 00000 n\r\n0000009790 00000 n\r\n0000010428 00000 n\r\n0000011330 00000 n\r\n0000012497 00000 n\r\n0000013664 00000 n\r\n0000013720 00000 n\r\n0000027228 00000 n\r\n0000028549 00000 n\r\n0000029249 00000 n\r\n0000029888 00000 n\r\n0000031054 00000 n\r\n0000032166 00000 n\r\n0000032329 00000 n\r\n0000032470 00000 n\r\n0000033290 00000 n\r\n0000045052 00000 n\r\n0000045106 00000 n\r\n0000046158 00000 n\r\n0000046795 00000 n\r\n0000047960 00000 n\r\n0000048041 00000 n\r\n0000048462 00000 n\r\n0000049433 00000 n\r\n0000049472 00000 n\r\n0000050019 00000 n\r\n0000050153 00000 n\r\n0000093441 00000 n\r\n0000093741 00000 n\r\n0000093794 00000 n\r\n0000093895 00000 n\r\n0000094127 00000 n\r\n0000095139 00000 n\r\n0000096303 00000 n\r\n0000097203 00000 n\r\n0000098030 00000 n\r\n0000098857 00000 n\r\n0000108317 00000 n\r\n0000109273 00000 n\r\n0000111966 00000 n\r\n0000115264 00000 n\r
→ call run_python({"code":"import re, io, sys, json, textwrap\nimport requests\nfrom pypdf import PdfReader\n\nurls = {\n 'erratum': 'https://link.springer.com/content/pdf/10.1007/s12325-014-0150-8.pdf',\n 'original': 'https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf',\n}\nres = {}\nfor k,u in urls.items():\n r = requests.get(u, timeout=30)\n r.raise_for_status()\n reader = PdfRead)
【tool:run_python】
{"ok": true, "stdout": "\n### erratum len 4572 idx 801\n", "stderr": "Traceback (most recent call last):\n File \"C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\workspace\\_run_1777069524479.py\", line 22, in <module>\n print(txt[idx:idx+2500])\n ~~~~~^^^^^^^^^^^^^^^^^^^\n File \"C:\\Python313\\Lib\\encodings\\cp1252.py\", line 19, in encode\n return codecs.charmap_encode(input,self.errors,encoding_table)[0]\n ~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^\nUnicodeEncodeError: 'charmap' codec can't encode character '\\ufb01' in position 176: character maps to <undefined>\n", "returncode": 1}
→ call run_python({"code":"import re, io, json, sys, requests\nfrom pypdf import PdfReader\n\nurls = {\n 'erratum': 'https://link.springer.com/content/pdf/10.1007/s12325-014-0150-8.pdf',\n 'original': 'https://link.springer.com/content/pdf/10.1007/s12325-013-0060-1.pdf',\n}\nres = {}\nfor k,u in urls.items():\n r = requests.get(u, timeout=30)\n r.raise_for_status()\n reader = PdfReader(io.BytesIO(r.c)
【tool:run_python】
{"ok": true, "stdout": "ented at the\\n48th Annual Meeting of the American Society of Clinical\\nOncology; June 1�5, 2012; Chicago, IL. Abstract 559.\\nElectronic supplementary material The online\\nversion of this article (doi: 10.1007/s12325-013-0060-1)\\ncontains supplementary material, which is available to\\nauthorized users.\\nD. A. Yardley ( &) /C1H. A. Burris III\\nSarah Cannon Research Institute and Tennessee\\nOncology, PLLC, Nashville, TN 37203, USA\\ne-mail: dyardley@tnonc.com\\nS. Noguchi\\nDepartment of Breast and Endocrine Surgery, Osaka\\nUniversity, Suita, Osaka 565-0871, Japan\\nK. I. Pritchard\\nSunnybrook Odette Cancer Centre and the\\nUniversity of Toronto, Toronto, ON M4N 3M5,\\nCanada\\nJ. Baselga\\nMemorial Sloan-Kettering Cancer Center, New York,\\nNY 10065, USA\\nM. Gnant\\nDepartment of Surgery, Comprehensive Cancer\\nCenter, Medical University of Vienna, 1090 Vienna,\\nAustria\\nG. N. Hortobagyi\\nThe University of Texas MD Anderson Cancer\\nCenter, Houston, TX 77030, USA\\nM. Campone\\nInstitut de Cance�rologie de l�Ouest, Rene�\\nGauducheau, Centre de Recherche en Cance�rologie,\\n44805 Nantes Saint Herblain, France\\nEnhanced content for Advances in Therapy\\narticles is available on the journal web site:\\nwww.advancesintherapy.com\\n123\\nAdv Ther (2013) 30:870�884\\nDOI 10.1007/s12325-013-0060-1\\nNSAIs. The primary endpoint was PFS by local\\ninvestigator review, and was confirmed by\\nindependent central radiology review. Overall\\nsurvival
→ call web_search({"limit":10,"query":"\"10.1007/s12325-013-0060-1\" PMID"})
→ call web_search({"limit":10,"query":"\"BOLERO-2 Final Progression-Free Survival Analysis\" PMID"})
→ call web_search({"limit":10,"query":"site:europepmc.org/abstract/MED/ \"10.1007/s12325-013-0060-1\""})
→ call web_search({"limit":10,"query":"site:pubmed.ncbi.nlm.nih.gov \"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\""})
【tool:web_search】
{"ok": true, "query": "\"10.1007/s12325-013-0060-1\" PMID", "results": []}
【tool:web_search】
{"ok": true, "query": "\"BOLERO-2 Final Progression-Free Survival Analysis\" PMID", "results": []}
【tool:web_search】
{"ok": true, "query": "site:europepmc.org/abstract/MED/ \"10.1007/s12325-013-0060-1\"", "results": []}
【tool:web_search】
{"ok": true, "query": "site:pubmed.ncbi.nlm.nih.gov \"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\"", "results": []}
→ call web_search({"limit":10,"query":"\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" PubMed"})
→ call web_search({"limit":10,"query":"\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\" PubMed PMID"})
→ call web_search({"limit":10,"query":"\"BOLERO-2 Final Progression-Free Survival Analysis\" Europe PMC PMID"})
【tool:web_search】
{"ok": true, "query": "\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis\" PubMed", "results": []}
【tool:web_search】
{"ok": true, "query": "\"Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer\" PubMed PMID", "results": []}
【tool:web_search】
{"ok": true, "query": "\"BOLERO-2 Final Progression-Free Survival Analysis\" Europe PMC PMID", "results": []}
【assistant】
本轮结论：**已经把 BOLERO-2 原文和 erratum 的摘要边界锁定了，且修订范围明确只在摘要里的“prospectively defined subgroups”表述，不涉及 PFS 数值或主结论。**
已确认的可引用事实：
- 原文 DOI：10.1007/s12325-013-0060-1
- 勘误 DOI：10.1007/s12325-014-0150-8
- 勘误 PMCID：PMC4713958
- 原文
```